A Little about Kepley BioSystems
Kepley BioSystems Inc was born of the novel idea that a product that can do good is a good product. Realizing that there was a need for a new model for crustacean fishing, we set forth to deliver a product that would be much easier to use, store, and afford than traditional bait methods, but also reduce the impact on our already over burdened oceans. From there, we've developed our Organobait, a fully synthetic bait product that will allow fishermen to catch more crab and lobster without the need of expensive traditional bait fish and lessens the demand of forage fish being taken from the ecosystem.
We are currently based out of Greensboro, North Carolina. Our team is small, but dedicated to reducing the demands currently mounting against our oceanic ecosystems. We have teamed up with professional crustacean fishers from around the globe to help us complete our research and development. The Kepley BioSystems team is proud of what we've accomplished and can't wait to see how far our impact can reach.
The People Behind Kepley BioSystems
Anthony L. Dellinger PhD
Dr. Anthony Dellinger serves as President and Scientist. He has a biology background, including marine sciences. Dr. Dellinger’s expertise includes attractant molecular matter and chemistry, facilitating the invention and engineering of synthetic agents. He holds a BS in Forensic Molecular Biology with a Minor in Chemistry and a PhD in Nanoscience. He has authored or co-authored numerous peer-reviewed publications and has collaborated with Dr. Kepley for a decade in academia and industry. Dr. Dellinger’s PhD project was the stimulus for this technology, and he continues with these scientific refinements. He was recently named the inaugural Entrepreneur of the Year for 2015 at his alma mater, the University of North Carolina. He is one of three crustacean panelists selected for the 2015 International BioMarine© conference.
Christopher L. Kepley PhD
Professor Kepley has a comprehensive biology research background and is recognized internationally for his work, much of which he has shared in 80 peer-reviewed publications. In business, Dr. Kepley was the Group Leader of NanoBiology at Luna Innovations, where he increased revenue by $2 million during his three years as a full-time executive. His inventions have resulted in 11 issued patents for products in active commerce, notably, the first basophil-specific antibody (2D7) currently sold through several biotech companies. Dr. Kepley holds a tenured professorship at the Joint School of Nanoscience and Nanoengineering. He has a BS in Biology, a PhD from Medical College of Virginia, and an MBA from the College of William and Mary.
Terry Brady’s 35 years of leadership experience includes global sales, marketing, invention/entrepreneurship, and executive management. Seasoned by early positions in multi nationals, including Johnson & Johnson, Richardson Vicks (purchased by Proctor and Gamble) and Union Carbide, Mr. Brady ultimately served as president of International Technidyne Corporation (ITC), Edison, NJ (now Accriva Diagnostics, San Diego, CA) and as founder, president and CEO of Array Medical, Inc., Somerville, NJ. In both roles, he led the growth and ultimate divestiture of the two companies: ITC to a Fortune 500 leader, ThermoElectron (394 in 1999); and Array to Helena Laboratories. In addressing customer needs, Mr. Brady was the lead inventor of four US patented products and numerous others with FDA-approval that remain in active commerce – many of which still enjoy segment dominance. During the first year of Array Medical operation, he conceived, developed, and conducted clinical trials for FDA approval of a major cardiovascular product. Successfully manufacturing and marketing this product through 50 worldwide dealers epitomized Mr. Brady’s mastery of traditional manufacturing operations, direction of an in-house marketing agency, and of establishing hundreds of relationships in a global dealership distribution business model. Most recently, he has qualified for a commercial fishing license in relation to this bait invention and hands-on validation of the technology with spiny lobster and stone crab.
Lance Tōland Associates Ltd. was established in August of 1975 after founder Lance Tōland recognized the need for a monoline aviation insurance agency with both insurance savvy and a dedicated commitment to clients.
With more than 30 years in the industry, Lance Tōland is an established leader in the field of aviation insurance services. His main office in Metro Atlanta is just minutes from facilities for every major aviation underwriter in the industry, allowing the agency to maintain close and productive working relationships with senior industry specialists.
Lance is a published author, sharing his expertise in publications such as Business and Commercial Aviation, Forbes and Falcon Owners Newsletter. His regular aviation insurance column, "Ask Lance Tōland," appears in the Pilatus Owners and Pilots Association quarterly newsletter. Georgia Governor Sonny Perdue appointed Lance to his Aviation Task Force, which investigated state aviation resources regarding risk management, safety practices and overall efficiency. The undertaking resulted in a total revamp of the State's aviation assets, saving Georgia taxpayers millions of dollars and the implementation of many safety initiatives.
Rachel Kulberg PhD
NSF Research Experience for Undergraduates Program
The National Science Foundation funds a large number of research opportunities for undergraduate students through its Research Experience for Undergraduates (REU) program. Kepley BioSystems Inc is proud have been selected to be such a site. Under the REU program, undergraduates gain valuable experience assisting in the research being performed by Kepley BioSystems by working closely with our team.
Waleed Ali is a rising sophomore at Columbia University majoring in biology, utilizing the NSF REU program in order to explore the finer parts of analytical chemistry and the rapidly expanding field of nanoscience in general. Previously, his research experience involved working at a pathology lab in which his most recent work led to a poster at the national USCAP (United States and Canadian Academy of Pathology) conference last spring, as well as an NSF sponsored internship at a biotech company dealing with isolating circulating tumor cells, in which he cultured cells and worked on process automation. In his spare time, he enjoys playing quizbowl, obsessing about proper data visualization, and long walks on the beach (searching for crabs).
Cammie (Cambarus Hobbsorum)
The Kepley BioSystems Lab mascot, Cammie, enjoys a life of leisure while overseeing the production of OrganoBait. Indigenous to the nearby rivers in Greensboro, North Carolina, she joined the Kepley team in early June. Crayfish, also known as freshwater lobsters, share many biological commonalities with their larger arthropoda phylum. When not snacking on OrganoBait, she can be found studiously moving stones around in her tank.
As a member of the Nanomanufacturing Innovation Consortium (NIC), Kepley BioSystems Inc is currently located at the Gateway University Research Park facility in Greensboro, North Carolina. The NIC enables access to the adjacent Joint School of Nanoscience and Nanoengineering (JSNN), a state-of-the-art research and education facility. The Joint School provides access to unique capabilities for product development, analytical services, materials testing, analysis, and evaluation, perfectly suiting the needs of Kepley BioSystems as we further refine and adapt OrganoBait.